Viiv

[anonymous]

How's the Cabenuva launch going? Heard you guys can't give it away.

Going better than you know. How are your break through blips going

 

[anonymous]

Going better than you know. How are your break through blips going

Stop it! Blips aren’t uncommon! Blips are more often than not lab issues. Resistance in clinical trials IS uncommon in today’s antiretroviral world. The last three ViiV dawgs all show resistance in clinical trials. “The Shot” even shows resistance WHILE PATIENTS ARE COMPLIANT ON IT!!!!! If ViiV’s last three dawgs could achieve more than the <10% combined they currently hold maybe they’d see blips? The regimens that actually get prescribed is where blips are going to be seen.

 

[anonymous]

Let’s just put this to bed right now and end this nonsense. Yes or no, has resistance been seen in the last three approved ViiV dawgs....errrr regimens? Yes or no, has there been resistance seen in ANY of the Biktarvy clinical trials? Hopefully, your opinion won’t get in the way of facts!

 

[anonymous]

We lost credibility with Juluca, pushed it farther down with Dovato, and now are begging for a Cab prescription- Gilead doesn’t consider us a competitor or threat anymore - we are competing with the Merck’s and the Johnson and Johnson’s for the patients remaining after Gilead takes their fair Shari (60-70%). We fight for that 30% with everyone else with inferior products

 

[anonymous]

Interesting the last few posts are obviously Gilead stirring the pot. Gilead is a sinking ship paying greedy doctors dealing with a drug that is blipping and conferences taking about known Gilead resistance. Haven’t heard of a study or conference taking about Viivs products having these issues. So troll back to your page and live in make believe land.

 

[anonymous]

Interesting the last few posts are obviously Gilead stirring the pot. Gilead is a sinking ship paying greedy doctors dealing with a drug that is blipping and conferences taking about known Gilead resistance. Haven’t heard of a study or conference taking about Viivs products having these issues. So troll back to your page and live in make believe land.

ViiV still has HIV products? For real?

 

[anonymous]

Interesting the last few posts are obviously Gilead stirring the pot. Gilead is a sinking ship paying greedy doctors dealing with a drug that is blipping and conferences taking about known Gilead resistance. Haven’t heard of a study or conference taking about Viivs products having these issues. So troll back to your page and live in make believe land.

ViiV solely exists today to muddy the water. They have NOTHING to offer! They’re eerily similar to the ReTrumplican Party. They have no platform but only existing to talk about how bad Gilead’s products are for patients. Management has tasked them with selling as new a 25 year old GENERIC drug combined with a 10 year old drug WITH clinical trial resistance (see 144 week data). First they talked about how bad a booster is with Genvoya then it was TAF and weight gain with Biktarvy and now it’s blips. Funny how TAF was fine when ViiV was pushing it with Tivicay because they never developed a decent drug to a pair with it. ViiV is grasping at straws to hold on to relevancy, their eroding Triumeq market share and <10% combined market share for their last three abysmal drug launches.

 

[anonymous]

Interesting the last few posts are obviously Gilead stirring the pot. Gilead is a sinking ship paying greedy doctors dealing with a drug that is blipping and conferences taking about known Gilead resistance. Haven’t heard of a study or conference taking about Viivs products having these issues. So troll back to your page and live in make believe land.

You can say what you want about Gilead. but they are the king. Viiv gets the crumbs, if even that. You don't like it but that doesn't change the facts.

 

[anonymous]

I was offered a new job today at a different company. I am so excited to get away from ViiV - the HIV products I have sold here are a joke. Absolute crap that no Provider wants to use. Can’t wait to give my notice

 

[anonymous]

Pay attention people. First, we are not an independent company, we are GSK. Second, major hedge fund, Elliott Investments, just invested billions..yes with an "s", billions into GSK stock. Why would they do that? Share price has been abysmal for decades and only getting worse. Product pipelines have been a huge disappointment. Look at the recent oncology failures. You can forget about Respiratory. They are having a layoff with more to come. Our division? 2DR has been a huge failure! Oral or injectable...massive disappointments! So why would a hedge-fund invest so heavily into a sinking organization? Allow me to give you the magic answer....GSK will be bought. Once announced our shares will climb. Great for shareholders, bad for rank and file employees. You all heard about the new severance policy...no longer 2 weeks per year. Now its 6 months max severance. Those of you who stuck around for the "big payday" will be disappointed. You tolerated humiliation for years and now will suffer the ultimate when you are $hit canned next year. Allow me one last piece of advice...GTFO! Leave while you can. On your own terms with your head held high! For those of you with an ounce of talent there are better jobs where you will make more money and be treated better. Or continue to kick it at GSK. Long work contacts, trackers, role-plays, and outlandish sales objectives. Do as you will. I just accepted a job yesterday. Gave notice ...you know who I am. So you know I speak the truth. Best of luck to all!

 

[anonymous]

Pay attention people. First, we are not an independent company, we are GSK. Second, major hedge fund, Elliott Investments, just invested billions..yes with an "s", billions into GSK stock. Why would they do that? Share price has been abysmal for decades and only getting worse. Product pipelines have been a huge disappointment. Look at the recent oncology failures. You can forget about Respiratory. They are having a layoff with more to come. Our division? 2DR has been a huge failure! Oral or injectable...massive disappointments! So why would a hedge-fund invest so heavily into a sinking organization? Allow me to give you the magic answer....GSK will be bought. Once announced our shares will climb. Great for shareholders, bad for rank and file employees. You all heard about the new severance policy...no longer 2 weeks per year. Now its 6 months max severance. Those of you who stuck around for the "big payday" will be disappointed. You tolerated humiliation for years and now will suffer the ultimate when you are $hit canned next year. Allow me one last piece of advice...GTFO! Leave while you can. On your own terms with your head held high! For those of you with an ounce of talent there are better jobs where you will make more money and be treated better. Or continue to kick it at GSK. Long work contacts, trackers, role-plays, and outlandish sales objectives. Do as you will. I just accepted a job yesterday. Gave notice ...you know who I am. So you know I speak the truth. Best of luck to all!

Keep hearing multiple projections on severance. You said no longer 2 weeks per year and maximum in 6 months. I thought the 2 weeks per year is still valid with max well beyond 6 months.

 

[anonymous]

Not anymore. GSK hired an outside consulting company which advised to cut severance packages. If you don't believe me just ask those who were on last weeks HR call in the Respiratory division. 6 months max payout. The glory days of living high on the hog are but a distant memory. If you enjoy what your doing and how you are treated, stay on. If not, I would get out ASAP! I did and will be making 15K more on my base with a higher bonus potential..more importantly, an attainable quota. When I inquired about role-playing they had no idea what I was talking about. Probably thought I was some sex deviant. GSK / ViiV are toxic! See ya on the other side my friends.

 

[anonymous]

Not anymore. GSK hired an outside consulting company which advised to cut severance packages. If you don't believe me just ask those who were on last weeks HR call in the Respiratory division. 6 months max payout. The glory days of living high on the hog are but a distant memory. If you enjoy what your doing and how you are treated, stay on. If not, I would get out ASAP! I did and will be making 15K more on my base with a higher bonus potential..more importantly, an attainable quota. When I inquired about role-playing they had no idea what I was talking about. Probably thought I was some sex deviant. GSK / ViiV are toxic! See ya on the other side my friends.

I think you made a wise choice. I am looking. It’s humiliating selling Dovato and now Cab. Nobody wants these products- they are huge steps backwards. ViiV is a dumpster fire

 

[anonymous]

Pay attention people. First, we are not an independent company, we are GSK. Second, major hedge fund, Elliott Investments, just invested billions..yes with an "s", billions into GSK stock. Why would they do that? Share price has been abysmal for decades and only getting worse. Product pipelines have been a huge disappointment. Look at the recent oncology failures. You can forget about Respiratory. They are having a layoff with more to come. Our division? 2DR has been a huge failure! Oral or injectable...massive disappointments! So why would a hedge-fund invest so heavily into a sinking organization? Allow me to give you the magic answer....GSK will be bought. Once announced our shares will climb. Great for shareholders, bad for rank and file employees. You all heard about the new severance policy...no longer 2 weeks per year. Now its 6 months max severance. Those of you who stuck around for the "big payday" will be disappointed. You tolerated humiliation for years and now will suffer the ultimate when you are $hit canned next year. Allow me one last piece of advice...GTFO! Leave while you can. On your own terms with your head held high! For those of you with an ounce of talent there are better jobs where you will make more money and be treated better. Or continue to kick it at GSK. Long work contacts, trackers, role-plays, and outlandish sales objectives. Do as you will. I just accepted a job yesterday. Gave notice ...you know who I am. So you know I speak the truth. Best of luck to all!

See the link below and

Emma Walmsley knows this as the wheels are in motion.

Personally, I liked it at ViiV until we went 3 up in July 2017 and became primary care “reach and frequency”. I jumped over then and we became what existed and with the same RSDs.

After 20 plus after riding this since mid 2017. ViiV is not a bad place to coast to finish, but a bad place to start.

https://www.bloomberg.com/news/arti...axo-piles-pressure-on-ceo-to-speed-turnaround

 

[anonymous]

See the link below and

Emma Walmsley knows this as the wheels are in motion.

Personally, I liked it at ViiV until we went 3 up in July 2017 and became primary care “reach and frequency”. I jumped over then and we became what existed and with the same RSDs.

After 20 plus after riding this since mid 2017. ViiV is not a bad place to coast to finish, but a bad place to start.

https://www.bloomberg.com/news/arti...axo-piles-pressure-on-ceo-to-speed-turnaround

Agree. Start looking if you haven’t already. This is primary care at best. With launches done like primary care products. Sick of hearing this is how all Injectables are launched with closed networks. WAKE UP PEOPLE THIS IS HIV not a cardio injection. The doctors and academic facilities are different than your OLD FAILED way of thinking. Then lets push useless programs on people that have the same slides as TAMs

 

[anonymous]

Agree. Start looking if you haven’t already. This is primary care at best. With launches done like primary care products. Sick of hearing this is how all Injectables are launched with closed networks. WAKE UP PEOPLE THIS IS HIV not a cardio injection. The doctors and academic facilities are different than your OLD FAILED way of thinking. Then lets push useless programs on people that have the same slides as TAMs

I know - they claim this is normal, after claiming the Juluca/Dovato terrible launches were “normal” - of course after decreasing expectations 3 or 4 times

 

[anonymous]

I cant imagine that activist investor Elliot's billion dollar stake in GSK is not going to affect Viiv which is now running an entire company on the fumes of the Dolutegravir franchise. It does not take an investing whiz to know that Viiv is coming up short of all the sales goals it set for Dovato, Juluca and most likely Cab.
Anyone know what Cab sales look like? It's unlikely that too many people are lining up to get 2 ass shots every month when they could just take a pill at home.

 

[anonymous]

I cant imagine that activist investor Elliot's billion dollar stake in GSK is not going to affect Viiv which is now running an entire company on the fumes of the Dolutegravir franchise. It does not take an investing whiz to know that Viiv is coming up short of all the sales goals it set for Dovato, Juluca and most likely Cab.
Anyone know what Cab sales look like? It's unlikely that too many people are lining up to get 2 ass shots every month when they could just take a pill at home.

While Cab utilization is most likely extremely light, our management will adjust company goals based on “Covid” or some other excuse - just like they did with Dovato. Meanwhile, we will continue to get our asses kicked by our competitors and micromanaged to death - good times

 

[anonymous]

ViiV solely exists today to muddy the water. They have NOTHING to offer! They’re eerily similar to the ReTrumplican Party. They have no platform but only existing to talk about how bad Gilead’s products are for patients. Management has tasked them with selling as new a 25 year old GENERIC drug combined with a 10 year old drug WITH clinical trial resistance (see 144 week data). First they talked about how bad a booster is with Genvoya then it was TAF and weight gain with Biktarvy and now it’s blips. Funny how TAF was fine when ViiV was pushing it with Tivicay because they never developed a decent drug to a pair with it. ViiV is grasping at straws to hold on to relevancy, their eroding Triumeq market share and <10% combined market share for their last three abysmal drug launches.

I’ve been with ViiV since TIVICAY (DTG) launch.

This is sadly 100% on point.

 

[anonymous]

I’ve been with ViiV since TIVICAY (DTG) launch.

This is sadly 100% on point.

Such an innovative company. A moron came up with that strategy. The division is set to crumble and this is not news to anyone.